Exclusive Summary

• Omeprazole for injection is a first-line emergency emergency drug for acute GI bleeding and ICU care, offering massive and highly stable procurement demand in global hospitals.
• With original patents long expired, this classic essential medicine poses zero intellectual property barriers, ensuring extreme low risk for market access.
• Included in the WHO Essential Medicines List and major international guidelines, it requires zero market education and serves as a perfect cornerstone product for distribution pipelines.
• Leveraging China's mature supply chain and massive production capacity, it holds a significant cost advantage, providing overseas distributors with high margins to win local hospital tenders.
• The supplier can provide ICH-compliant CTD dossiers to support rapid local registration and smooth execution of distribution agreements.